Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.

Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.

Item
http://www.wikidata.org/entity/Q40382272
miR-221&222 regulate TRAIL resistance and enhance tumorigenicity through PTEN and TIMP3 downregulationGSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of SlugMAP kinase pathways and calcitonin influence CD44 alternate isoform expression in prostate cancer cells.Phenethyl isothiocyanate sensitizes androgen-independent human prostate cancer cells to docetaxel-induced apoptosis in vitro and in vivo.p27 suppresses arsenite-induced Hsp27/Hsp70 expression through inhibiting JNK2/c-Jun- and HSF-1-dependent pathways.Dependence on the MUC1-C oncoprotein in non-small cell lung cancer cells.Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC.Restoring KLF5 in esophageal squamous cell cancer cells activates the JNK pathway leading to apoptosis and reduced cell survival.PI3K p110β isoform synergizes with JNK in the regulation of glioblastoma cell proliferation and migration through Akt and FAK inhibition.Simultaneous blockade of AP-1 and phosphatidylinositol 3-kinase pathway in non-small cell lung cancer cellsLiposomal encapsulation of deguelin: evidence for enhanced antitumor activity in tobacco carcinogen-induced and oncogenic K-ras-induced lung tumorigenesis.Nitric oxide inactivates the retinoblastoma pathway in chronic inflammation.PA28gamma emerges as a novel functional target of tumour suppressor microRNA-7 in non-small-cell lung cancer.Targeting the Mammalian Target of Rapamycin in Lung Cancer.Suppression of AKT expression by miR-153 produced anti-tumor activity in lung cancer.Daunorubicin induces cell death via activation of apoptotic signalling pathway and inactivation of survival pathway in muscle-derived stem cells.Combined treatment of curcumin and small molecule inhibitors suppresses proliferation of A549 and H1299 human non-small-cell lung cancer cells.
P2860

Response of non-small cell lung cancer cells to the inhibitors of phosphatidylinositol 3-kinase/Akt- and MAPK kinase 4/c-Jun NH2-terminal kinase pathways: an effective therapeutic strategy for lung cancer.

Item
http://www.wikidata.org/entity/Q40382272
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Response of non-small cell lun ...... utic strategy for lung cancer.
@en
type
label
Response of non-small cell lun ...... utic strategy for lung cancer.
@en
prefLabel
Response of non-small cell lun ...... utic strategy for lung cancer.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P698
P356
P1433
P1476
Response of non-small cell lun ...... utic strategy for lung cancer.
@en
P2093
P304
P31
P356
10.1158/1078-0432.CCR-05-0009
P407
P433
P478
P577
P698